9-95099155-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_000136.3(FANCC):​c.*2552T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.026 in 215,522 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.027 ( 84 hom., cov: 31)
Exomes 𝑓: 0.023 ( 23 hom. )

Consequence

FANCC
NM_000136.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.24

Publications

8 publications found
Variant links:
Genes affected
FANCC (HGNC:3584): (FA complementation group C) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
AOPEP (HGNC:1361): (aminopeptidase O (putative)) This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BP6
Variant 9-95099155-A-G is Benign according to our data. Variant chr9-95099155-A-G is described in ClinVar as [Benign]. Clinvar id is 367569.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0272 (4138/152310) while in subpopulation AMR AF = 0.0433 (662/15306). AF 95% confidence interval is 0.0405. There are 84 homozygotes in GnomAd4. There are 2057 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 84 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCCNM_000136.3 linkc.*2552T>C 3_prime_UTR_variant Exon 15 of 15 ENST00000289081.8 NP_000127.2 Q00597A0A024R9N2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCCENST00000289081.8 linkc.*2552T>C 3_prime_UTR_variant Exon 15 of 15 1 NM_000136.3 ENSP00000289081.3 Q00597
FANCCENST00000375305.6 linkc.*2552T>C 3_prime_UTR_variant Exon 15 of 15 1 ENSP00000364454.1 Q00597
AOPEPENST00000710812.1 linkn.410+18375A>G intron_variant Intron 4 of 4
FANCCENST00000696260.1 linkn.*45T>C downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0272
AC:
4138
AN:
152192
Hom.:
84
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00644
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0431
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0220
Gnomad FIN
AF:
0.0544
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0357
Gnomad OTH
AF:
0.0263
GnomAD4 exome
AF:
0.0231
AC:
1463
AN:
63212
Hom.:
23
Cov.:
0
AF XY:
0.0233
AC XY:
682
AN XY:
29312
show subpopulations
African (AFR)
AF:
0.00495
AC:
14
AN:
2828
American (AMR)
AF:
0.0486
AC:
87
AN:
1790
Ashkenazi Jewish (ASJ)
AF:
0.00939
AC:
38
AN:
4048
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9308
South Asian (SAS)
AF:
0.0148
AC:
8
AN:
540
European-Finnish (FIN)
AF:
0.0370
AC:
2
AN:
54
Middle Eastern (MID)
AF:
0.00761
AC:
3
AN:
394
European-Non Finnish (NFE)
AF:
0.0305
AC:
1189
AN:
38972
Other (OTH)
AF:
0.0231
AC:
122
AN:
5278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0272
AC:
4138
AN:
152310
Hom.:
84
Cov.:
31
AF XY:
0.0276
AC XY:
2057
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00642
AC:
267
AN:
41578
American (AMR)
AF:
0.0433
AC:
662
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.0218
AC:
105
AN:
4822
European-Finnish (FIN)
AF:
0.0544
AC:
577
AN:
10616
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0357
AC:
2430
AN:
68024
Other (OTH)
AF:
0.0260
AC:
55
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
205
410
616
821
1026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0302
Hom.:
103
Bravo
AF:
0.0248
Asia WGS
AF:
0.0100
AC:
36
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Fanconi anemia complementation group C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.087
DANN
Benign
0.28
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9673; hg19: chr9-97861437; API